ArticleOxford medical case reports2015

CPT-11/bevacizumab for the treatment of refractory brain metastases in patients with HER2-neu-positive breast cancer.

S Sengupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.